Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Fuji
Chubb
Mallinckrodt
Harvard Business School
UBS
Teva
Cantor Fitzgerald
Cerilliant
Johnson and Johnson

Generated: August 22, 2017

DrugPatentWatch Database Preview

FLEXERIL Drug Profile

« Back to Dashboard

Which patents cover Flexeril, and what generic Flexeril alternatives are available?

Flexeril is a drug marketed by Janssen Res And Dev and is included in one NDA.

The generic ingredient in FLEXERIL is cyclobenzaprine hydrochloride. There are fifteen drug master file entries for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the cyclobenzaprine hydrochloride profile page.

Summary for Tradename: FLEXERIL

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list65
Clinical Trials: see list7
Patent Applications: see list674
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FLEXERIL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Res And Dev
FLEXERIL
cyclobenzaprine hydrochloride
TABLET;ORAL017821-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Janssen Res And Dev
FLEXERIL
cyclobenzaprine hydrochloride
TABLET;ORAL017821-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: FLEXERIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Res And Dev
FLEXERIL
cyclobenzaprine hydrochloride
TABLET;ORAL017821-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Janssen Res And Dev
FLEXERIL
cyclobenzaprine hydrochloride
TABLET;ORAL017821-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Janssen Res And Dev
FLEXERIL
cyclobenzaprine hydrochloride
TABLET;ORAL017821-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Janssen Res And Dev
FLEXERIL
cyclobenzaprine hydrochloride
TABLET;ORAL017821-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Chinese Patent Office
QuintilesIMS
Baxter
Dow
Colorcon
Federal Trade Commission
Queensland Health
Argus Health
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot